* iRhythm Technologies Inc IRTC.OQ reported a quarterly
adjusted
loss of $1.26 per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -67 cents. The mean expectation of twelve analysts for
the quarter was for a loss of 60 cents per share. Wall Street
expected results to range from -81 cents to -25 cents per share.
* Revenue rose 17.7% to $132.51 million from a year ago;
analysts
expected $130.24 million.
* iRhythm Technologies Inc's reported EPS for the quarter
was a
loss of $1.26.
* The company reported a quarterly loss of $38.7 million.
* iRhythm Technologies Inc shares had risen by 4.6% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for iRhythm
Technologies Inc is $125.00
This summary was machine generated from LSEG data February 23 at
03:01 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.60 -1.26 Missed
Sep. 30 2023 -0.66 -0.89 Missed
Jun. 30 2023 -0.78 -0.61 Beat
Mar. 31 2023 -0.90 -1.10 Missed